Moreover, the levels of RUNX3 P2 methylation, expressed as medians, did not differ across E1–E4 colitis (sequentially: E1 56.9% vs. E2 51.5% vs. E3 57.2% vs. E4 54.0%, H = 0.9412, p = 0.8155, and Chi2 = 1.5077, p = 0.6805). Here, RUNX3 is linked to colitis.